6MOA
C-terminal bromodomain of human BRD2 in complex with 4-(2-cyclopropyl-7-(6-methylquinolin-5-yl)-1H-benzo[d]imidazol-5-yl)-3,5-dimethylisoxazole inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 5.0.1 |
Synchrotron site | ALS |
Beamline | 5.0.1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2015-08-20 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 0.97741 |
Spacegroup name | P 2 21 21 |
Unit cell lengths | 31.947, 52.514, 72.000 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 29.202 - 1.271 |
R-factor | 0.1662 |
Rwork | 0.165 |
R-free | 0.17900 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.005 |
RMSD bond angle | 0.802 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | EPMR |
Refinement software | PHENIX ((1.10.1_2155: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 1.290 |
High resolution limit [Å] | 1.270 | 1.270 |
Rmerge | 0.032 | 0.209 |
Number of reflections | 108525 | 1580 |
<I/σ(I)> | 28.4 | |
Completeness [%] | 99.1 | 98.4 |
Redundancy | 3.3 | 3.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 12% PEG 1000 100mM NaTris-HCl pH 8.4 |